COMPAGNIE LOMBARD ODIER SCMA – Novo Nordisk A/S Transaction History
COMPAGNIE LOMBARD ODIER SCMA portfolio value:
$634,000
portfolio value
Novo Nordisk A/S 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 6.35K shares | 634K | $99.63 | 6.35K |
| Q1 2018 | share | Decrease | -100.00% | -50 shares | -3K | $46.15 | 0 |
| Q4 2017 | share | Decrease | -99.78% | -22.85K shares | -1.09M | $49.61 | 50 |
| Q3 2017 | share | 0.00% | 0 shares | 120K | $44.5 | 22.9K | |
| Q2 2017 | share | Decrease | -5.76% | -1.4K shares | 149K | $39.35 | 22.9K |
| Q1 2017 | share | Increase | 0.00% | 24.3K shares | 833K | $31.45 | 24.3K |